Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-14

Clinical Trial Update: Phase III Study of HRS-7535 for Hypertension With Overweight or Obesity [Phase 3]

View source ↗

Summary

This entry notes a Phase 3 clinical trial of HRS-7535 for hypertension in patients who are overweight or obese, with the study status listed as not yet recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HRS-7535 (HRS-7535)

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Hypertension With Overweight or Obesity | Phase 3 | Status: NOT_YET_RECRUITING